Health
Regeneron, J&J Get US Funding to Develop New Covid Vaccines, Treatments
Covid’s mutations have continued to outrun vaccines and treatments
Photographer: Thomas Kienzle/AFP/Getty ImagesThis article is for subscribers only.
Regeneron and Johnson & Johnson will receive millions of dollars in US government funding as part of a $5 billion initiative to develop next-generation vaccines and treatments for Covid-19.
Some $1.4 billion in funding will target projects including trials to enable the rapid development of more effective and longer-lasting coronavirus vaccines, new Covid antibody therapies and technologies to streamline manufacturing processes, the Department of Health and Human Services said Tuesday. The awards are the first in the Biden administration’s Project NextGen initiative that was announced in April.